SK279435B6 - Spôsob prípravy opticky čistého (6r alebo 6s)-dias - Google Patents

Spôsob prípravy opticky čistého (6r alebo 6s)-dias Download PDF

Info

Publication number
SK279435B6
SK279435B6 SK6103-90A SK610390A SK279435B6 SK 279435 B6 SK279435 B6 SK 279435B6 SK 610390 A SK610390 A SK 610390A SK 279435 B6 SK279435 B6 SK 279435B6
Authority
SK
Slovakia
Prior art keywords
tetrahydrofolic acid
salt
acid
ester
formyl
Prior art date
Application number
SK6103-90A
Other languages
English (en)
Slovak (sk)
Other versions
SK610390A3 (en
Inventor
Gerhard Schlingmann
Stuart A. Rosenfeld
Original Assignee
American Cyanamid Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Company filed Critical American Cyanamid Company
Publication of SK610390A3 publication Critical patent/SK610390A3/sk
Publication of SK279435B6 publication Critical patent/SK279435B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/842Clostridium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SK6103-90A 1989-12-11 1990-12-07 Spôsob prípravy opticky čistého (6r alebo 6s)-dias SK279435B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44966289A 1989-12-11 1989-12-11

Publications (2)

Publication Number Publication Date
SK610390A3 SK610390A3 (en) 1998-11-04
SK279435B6 true SK279435B6 (sk) 1998-11-04

Family

ID=23785009

Family Applications (1)

Application Number Title Priority Date Filing Date
SK6103-90A SK279435B6 (sk) 1989-12-11 1990-12-07 Spôsob prípravy opticky čistého (6r alebo 6s)-dias

Country Status (24)

Country Link
US (1) US5334535A (zh)
EP (1) EP0432441B1 (zh)
JP (1) JP3027613B2 (zh)
KR (1) KR0172118B1 (zh)
CN (1) CN1031804C (zh)
AR (1) AR245134A1 (zh)
AT (1) ATE139799T1 (zh)
AU (1) AU641710B2 (zh)
CA (1) CA2031784C (zh)
CZ (1) CZ279998B6 (zh)
DE (1) DE69027585T2 (zh)
DK (1) DK0432441T3 (zh)
ES (1) ES2090075T3 (zh)
FI (1) FI103804B (zh)
GR (1) GR3021060T3 (zh)
HU (1) HU209761B (zh)
IE (1) IE904439A1 (zh)
IL (1) IL96265A0 (zh)
NO (1) NO177541C (zh)
NZ (1) NZ236370A (zh)
PL (1) PL166096B1 (zh)
PT (1) PT96120B (zh)
SK (1) SK279435B6 (zh)
ZA (1) ZA909899B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH681303A5 (zh) * 1991-01-16 1993-02-26 Eprova Ag
DE4136921A1 (de) * 1991-11-11 1993-05-13 Knoll Ag Verfahren zur trennung von 5-methyl-tetrahydrofolsaeure
CH683262A5 (it) * 1992-01-22 1994-02-15 Applied Pharma Res Procedimento per la separazione dei diastereomeri del sale di calcio dell'acido (6(R,S)-N-formiltetraidrofolico).
IT1254635B (it) * 1992-02-20 1995-09-28 Bracco Spa Processo per la separazione degli stereoisomeri dell'acido folinico
CH686369A5 (de) * 1994-05-09 1996-03-15 Eprova Ag Stabile kristalline (6S)- und (6R)-Tetrahydrofolseure.
CH693255A5 (de) * 1997-06-13 2003-05-15 Eprova Ag Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
CH694251A5 (de) * 1999-07-14 2004-10-15 Eprova Ag Herstellung von Tetrahydropterin und Derivaten.
AU2001259039A1 (en) * 2000-04-05 2001-10-23 Edward V Quadros Radioenzymatic assay for methylenetetrahydrofolate reductase
CH696699A5 (de) * 2006-01-19 2007-10-15 Cerbios Pharma Sa Verfahren zur regioselektiven N(5) -Formylierung von (6S) -5, 6, 7, 8-Tetrahydropteroinsäure und Derivaten davon.
WO2010017526A1 (en) * 2008-08-08 2010-02-11 The Scripps Research Institute Purine nucleotides isotopically labeled in the purine base, methods of making thereof and uses thereof
US9382251B2 (en) * 2012-07-27 2016-07-05 Chemic Laboratories Inc. Compositions comprising folic acid derivatives, their preparations and methods of use
CN115656372B (zh) * 2022-10-27 2024-10-11 北京斯利安药业有限公司 一种s-四氢叶酸异构体手性分析方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500711A (en) * 1977-03-21 1985-02-19 Burroughs Wellcome Co. Synthesis of leucovorin
US4148999A (en) * 1977-08-22 1979-04-10 The Government Of The United States Of America Preparation and purification of citrovorum factor
GB8621268D0 (en) * 1986-09-03 1986-10-08 Univ Strathclyde Separation of substances
US4746662A (en) * 1987-02-20 1988-05-24 American Cyanamid Company Treatment of arthritis with 3,5-dichloromethotrexate
DE3821875C1 (zh) * 1988-06-29 1990-02-15 Eprova Ag, Forschungsinstitut, Schaffhausen, Ch
FR2643081B1 (fr) * 1989-02-14 1991-06-07 Panmedica Sa Folates de magnesium, procede de preparation et compositions pharmaceutiques
CH680731A5 (zh) * 1990-04-12 1992-10-30 Sapec Fine Chemicals
JPH07332120A (ja) * 1994-06-08 1995-12-22 Sanshin Ind Co Ltd 多気筒エンジン

Also Published As

Publication number Publication date
FI103804B1 (fi) 1999-09-30
DK0432441T3 (da) 1996-07-29
FI103804B (fi) 1999-09-30
IL96265A0 (en) 1991-08-16
NO177541C (no) 1995-10-04
ES2090075T3 (es) 1996-10-16
CZ279998B6 (cs) 1995-09-13
IE904439A1 (en) 1991-06-19
EP0432441A1 (en) 1991-06-19
JP3027613B2 (ja) 2000-04-04
KR0172118B1 (ko) 1999-02-01
NO905325D0 (no) 1990-12-10
DE69027585D1 (de) 1996-08-01
SK610390A3 (en) 1998-11-04
FI906072A0 (fi) 1990-12-10
AU6793290A (en) 1991-06-13
GR3021060T3 (en) 1996-12-31
KR910012262A (ko) 1991-08-07
CA2031784C (en) 2000-05-30
EP0432441B1 (en) 1996-06-26
HUT61335A (en) 1992-12-28
ATE139799T1 (de) 1996-07-15
CN1052509A (zh) 1991-06-26
CZ610390A3 (en) 1995-06-14
PT96120B (pt) 1998-08-31
AR245134A1 (es) 1993-12-30
CA2031784A1 (en) 1991-06-12
PT96120A (pt) 1991-09-30
JPH0491089A (ja) 1992-03-24
ZA909899B (en) 1991-10-30
AU641710B2 (en) 1993-09-30
HU908159D0 (en) 1991-06-28
HU209761B (en) 1994-10-28
PL288204A1 (en) 1991-12-16
NO905325L (no) 1991-06-12
NO177541B (no) 1995-06-26
FI906072A (fi) 1991-06-12
PL166096B1 (pl) 1995-03-31
CN1031804C (zh) 1996-05-15
US5334535A (en) 1994-08-02
NZ236370A (en) 1993-04-28
DE69027585T2 (de) 1997-01-16

Similar Documents

Publication Publication Date Title
JP2844532B2 (ja) 光学活性化合物の調製方法
SK279435B6 (sk) Spôsob prípravy opticky čistého (6r alebo 6s)-dias
US4510246A (en) Isolation of cyclase, epimerase and a ring expansion enzyme for producing unnatural cephalosporins
EP0457735B1 (en) Biocatalytic process for the production of L-(-)-carnitine from crotonobetaine and strains of Proteeae for use in said process
Arnstein et al. The biosynthesis of penicillin. 8. Investigation of cyclic cysteinylvaline peptides as precursors
US4822879A (en) Enzyme-inhibitory griseolic acid derivatives, and their use
US3923790A (en) Diaza-oxa-bicyclodecane derivatives and acyl derivatives thereof
US4771070A (en) CL-1957A antibiotic compound
KR100271997B1 (ko) Fa-70d물질, 이를 생산하기 위한 방법 및 그 용도
EP0173649A2 (en) Novel saframycin A derivatives and process for producing the same
US4260599A (en) Antifibrotic substance P-1894B
OKAZAKI et al. Studies of the Biosynthesis of Corrinoids and Porphyrinoids. IV. Biosynthesis of Chlorophyll in Euglena gracilis
JP2000072760A (ja) 新規シストチアゾール類縁体
EP1324980B1 (en) Citrullimycines, a process for their production and their use as pharmaceuticals
JP3596904B2 (ja) Fo−2295−i物質、fo−2295−ii物質および/またはfo−2295−iii 物質並びにその製造法
SK5442002A3 (en) Aromatic di-keto derivatives, processes for their production and their use as a pharmaceutical
US5081289A (en) Synthesis and isolation of nopaline and its analogues
Zygmunt et al. Formation of folic acid related compounds by Bacillus subtilis
JPH0258280B2 (zh)
JPH0358275B2 (zh)
JPH02174688A (ja) ジデオキシリバビリン誘導体及びその製造法
JPH08501215A (ja) 抗生物質ge2270因子aの生産を選択的に増加させる方法
JPS58159494A (ja) 新規抗生物質アゼピノマイシンおよびその製造法

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20101207